Skip to content
WeighLab
Menu
Ranked #323 · Grade C

GoodRx review

GoodRx is a NASDAQ-listed prescription discount platform, not a prescriber.

Visit GoodRx Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
Not disclosed
Tirzepatide
$299/mo (brand Zepbound, contract term)
Coverage
All 50 states
Brand-name
Yes

Tirzepatide · modeled / year

$3,588

Pricing verified August 2026

The Index scorecard

GoodRx scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month27/100
Price Transparency54/100
Nationwide Access86/100
Formulation Options66/100
Clinical Oversight68/100
Contract Flexibility47/100

Where the value is

  • Real FDA-approved brand medication, not compounded
  • 70,000+ pharmacy redemption network under the Lilly self-pay partnership
  • No membership fee — bring a prescription and use the card/program at the pharmacy counter

The tradeoffs

  • Direct verification of goodrx.com was blocked in this research session (403 on every fetch) — the figure above is corroborated via indexed snippets and GoodRx's own press release, not a page personally read live; a follow-up direct check is advisable
  • GoodRx is a discount/self-pay card, not a prescriber — a clinician visit is still required separately
  • Outside the specific Lilly self-pay partnership, an ordinary GoodRx coupon on brand Zepbound is only marginally below full cash price (~$1,060-$1,090/mo)

The bottom line

Best for: Cost-first shoppers who want self-pay access to brand-name Zepbound without a compounded product. GoodRx is a NASDAQ-listed prescription discount platform, not a prescriber.

Ranked #323 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to GoodRx.

The 24 programs nearest this one

Pricing, states and verification reflect GoodRx's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on GoodRx's site. Not medical advice; see our disclosure.

← Back to the value leaderboard